Nisa Investment Advisors LLC Sells 4,747 Shares of Axon Enterprise, Inc $AXON

Nisa Investment Advisors LLC cut its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 39.1% during the second quarter, Holdings Channel reports. The firm owned 7,396 shares of the biotechnology company’s stock after selling 4,747 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Axon Enterprise were worth $6,123,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Hemington Wealth Management raised its position in shares of Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 17 shares during the last quarter. Whipplewood Advisors LLC grew its stake in Axon Enterprise by 192.9% during the second quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock valued at $34,000 after acquiring an additional 27 shares in the last quarter. Washington Trust Advisors Inc. increased its holdings in Axon Enterprise by 44.7% in the 2nd quarter. Washington Trust Advisors Inc. now owns 55 shares of the biotechnology company’s stock valued at $46,000 after acquiring an additional 17 shares during the last quarter. TCTC Holdings LLC lifted its stake in Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after purchasing an additional 24 shares in the last quarter. Finally, Catalyst Capital Advisors LLC purchased a new stake in Axon Enterprise in the 1st quarter worth $32,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on AXON. Needham & Company LLC restated a “buy” rating and set a $870.00 price objective on shares of Axon Enterprise in a research report on Wednesday, September 24th. Raymond James Financial restated an “outperform” rating and set a $855.00 price target (up previously from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. UBS Group reaffirmed a “neutral” rating and issued a $840.00 price objective (up previously from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. JPMorgan Chase & Co. increased their target price on Axon Enterprise from $730.00 to $850.00 and gave the company an “overweight” rating in a research report on Thursday, July 17th. Finally, Craig Hallum upgraded shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price target on the stock in a research report on Tuesday, August 5th. Fourteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and an average price target of $841.64.

Insiders Place Their Bets

In related news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $713.74, for a total transaction of $7,137,400.00. Following the transaction, the chief executive officer directly owned 3,033,982 shares in the company, valued at approximately $2,165,474,312.68. This represents a 0.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jeri Williams sold 100 shares of the stock in a transaction dated Thursday, September 11th. The stock was sold at an average price of $752.54, for a total transaction of $75,254.00. Following the completion of the sale, the director directly owned 1,416 shares in the company, valued at $1,065,596.64. This trade represents a 6.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 59,932 shares of company stock valued at $45,115,616. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Trading Up 0.8%

Shares of AXON stock opened at $755.00 on Wednesday. The company has a market cap of $59.27 billion, a PE ratio of 186.42, a price-to-earnings-growth ratio of 29.09 and a beta of 1.41. Axon Enterprise, Inc has a 1 year low of $422.38 and a 1 year high of $885.91. The stock’s 50 day simple moving average is $732.26 and its two-hundred day simple moving average is $729.18. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company’s revenue for the quarter was up 32.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. Research analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.